Gut Microbes

Article	Citations
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	423
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	415
Modeling spatial interaction networks of the gut microbiota	405
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	359
Children’s gut microbiota predicts the efficacy of obesity treatment	357
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	304
Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH	250
Lactococcus lactis subsp. Cremoris reprograms systemic metabolism and protects against myocardial injury	247
Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease	210
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	202
Metabolic modeling links gut microbiota to metabolic markers of Parkinson’s disease	197
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	195
Decoding the HMO‒microbiome axis: bridging maternal milk to infant health outcomes	188
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	186
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	169
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	154
Intratumor Lactobacillus drives ferroptosis resistance via D-lactate-STAT3 K631 lactylation in esophageal squamous cell carcinoma	150
Contrasting dietary patterns remodel gut microbial function and generate multi-omic signatures associated with cardiometabolic markers	144
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	142
Bile salt hydrolase activity as a rational target for MASLD therapy	142
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	137
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	136
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic s	134
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	133
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	133

The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	131
Exercise improves gut microbial metabolites in an intensity-dependent manner: a pooled analysis of randomized controlled trials	130
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	129
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	128
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	126
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	124
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	124
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	124
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	120
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain f	119
Intestinal bacteria and colorectal cancer: etiology and treatment	117
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	117
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	113
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	112
Effect of diet on the evolution of gut commensal bacteria	112
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	111
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	110
Microbial extracellular vesicles from min pigs remodel macrophage polarization via STING to sustain intestinal immune homeostasis	108
Maternal gut microbiota mediates prenatal stress-induced fetal blood‒brain barrier dysfunction	106
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	105
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	104
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	103
Feeding microbes to feed the Gut: inulin reprograms intestinal epithelial metabolism and proliferation through HIF1α	101
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	101
The gut microbiome in graft-versus-host disease: mechanisms of immune modulation and therapeutic approaches	100
Exploring the gut microbiome and metabolomic interactions of antimetabolite drugs to optimize therapy	99
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	97
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	97
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	96
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	94
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	94
Unraveling multiple sclerosis: a hidden interaction between intestinal microbiota and host lipid metabolism	93
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	92
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	92
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	91
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data	90
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	90
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	89
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	89
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans	89
Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomiz	88
The emerging role of the gut microbiota in vaccination responses	88
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	87
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	87
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	87
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	86
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine gr	85
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	84
Helicobacter pylori activates histone lactylation to promote gastric cancer progression and immune evasion through the HAS2/c-MYC/PD-L1 axis	84
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	83

Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	83
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	83
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	82
Engineered bacteria as an orally administered anti-viral treatment and immunization system	82
Role and mechanism of gut microbiota and metabolites in schizophrenia complicated with sleep disorder	82
Akkermansia in the gastrointestinal tract as a modifier of human health	82
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	82
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	80
Immunoglobulin A protease from Sutterella wadsworthensis modifies outcome of infection with Campylobacter jejuni	80
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	79
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	78
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	78
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	76
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	76
Single cell viral tagging of Faecalibacterium prausnitzii reveals rare bacteriophages omitted by other techniques	75
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	75
Limousia bacteria encode mucinolysome for mucin utilization in animal gut microbiomes	74
Proteome profiling indicates a link between mitochondrial pathways and the host-microbial sensor ELMO1 following Salmonella infection	73
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	73
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	72
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	72
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	72
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	71
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	71
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	71
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer	69
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	69
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	69
Miniature bioreactor arrays for modeling functional and structural dysbiosis in inflammatory bowel disease	69
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	68
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	67
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carria	67
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	66
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	66
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	65
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	65
Gut microbiome and metabolic health: mechanisms and precision interventions	65
The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	65
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	64
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	64
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	64
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	64
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	63
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	63
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	63
Context-dependent roles of the gut microbiome in food allergy tolerance versus sensitization	62
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	62
The multifaceted virulence of adherent-invasive Escherichia coli	61
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection	61
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	61
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	61
Correction	61
The human gut microbiome and aging	61
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	61
Perinatal ampicillin exposure alters murine maternal fecal bile acid and acylcarnitine profiles	61
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	61
Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis	61
Metabolic pathway analysis reveals hierarchical pentose sugar utilization and metabolic flexibility of Bifidobacterium longum	60
The role of gut microbes in production of aromatic carboxaldehydes	60
Sulfide dynamics at the gut-microbiota interface: diet, oxygen and redox interplay	59
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	58
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	58
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	58
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	58
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tu	57
Colonic nutritional and physicochemical parameters drive gut microbiota dysbiosis in obesity: what we learned from the Ob-M-ARCOL model development	57
Gut microbiome at the crossroad of genetic variants and behavior disorders	57
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	56
Akkermansia muciniphila 's nifJ gene enhances colostrum sIgA synthesis by branched-chain amino acid degradation to branched sh	56
Infant gut microbiota restoration: state of the art	56
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	56
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	56
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	55
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	55
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	55
Staphylococcus haemolyticus is a reservoir of antibiotic resistance genes in the preterm infant gut	55
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	55
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	55
Gut microbial metabolites of amino acids in liver diseases	55
Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels	55

Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	55
Gut microbiota translocation and dissemination in health: can it be beneficial and purposeful?	55
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	55
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	55
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	55
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	55
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	54
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	54
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	54
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	53
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	53
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	53
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	53
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	53
Probiotic extracellular vesicles reprogram macrophage immunometabolism: From gut crosstalk to host health	53
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	53
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	52
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	52
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	52
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	52
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	51
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	51
Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	51
Exploring the etiology of colitis: insights from gut microbiota research	51
Using a human colonoid-derived monolayer to study bacteriophage translocation	51
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	51
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	50
Dual-source DPP4 drives intestinal fibrosis in Crohn’s disease: synergistic therapeutic targeting of host and microbiota pathways	50
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	50
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	50
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	50
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	49
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	49
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	49
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	49
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	48
Gut microbiome in type 2 diabetes: insights from metagenomics, multi-omics, and diet–microbe interactions	48
The interplay between PCOS pathology and diet on gut microbiota in a mouse model	48
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	48
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	48
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	48
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	47
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	47
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	47
Mucin-derived sugars act as metabolic brakes controlling growth initiation in Akkermansia muciniphila	47
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	47
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	47
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	47
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	47
Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity	46
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	46
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	46
Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease	46
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	46
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	46
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	46
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	46
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	46
Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives	45
Alteration of gut microbiota contributes to peritoneal fibrosis through increased production of trimethylamine N-oxide	45
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	44
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma	44
Myco-foods and the gut microbiome: impacts of mycelial extracts, biomass, and mold-fermented foods	44
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection	44
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	44
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	44
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	43
A commensal protozoan exacerbates acetaminophen-induced liver injury by producing free sphingosine	43
Diet standardization reduces intra-individual microbiome variation	43
DSS treatment does not affect murine colonic microbiota in absence of the host	43
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	43
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	43
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	42
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	42
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	42
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	42
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	42
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	42
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	42
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	41
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	41
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation	41
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	41
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	41
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	40
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	40
Autoinducer 2 as a universal language in microbial consortia: decoding molecular mechanisms, ecological impacts, and application	40
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	40
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	40
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	40
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	40
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	40
Better together– Salmonella biofilm-associated antibiotic resistance	40
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	40
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	39